1. Home
  2. CTMX vs MCFT Comparison

CTMX vs MCFT Comparison

Compare CTMX & MCFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$3.46

Market Cap

642.2M

Sector

Health Care

ML Signal

HOLD

Logo MasterCraft Boat Holdings Inc.

MCFT

MasterCraft Boat Holdings Inc.

HOLD

Current Price

$24.36

Market Cap

597.3M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTMX
MCFT
Founded
2008
1968
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Marine Transportation
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
642.2M
597.3M
IPO Year
2015
2015

Fundamental Metrics

Financial Performance
Metric
CTMX
MCFT
Price
$3.46
$24.36
Analyst Decision
Strong Buy
Hold
Analyst Count
10
5
Target Price
$12.10
$24.25
AVG Volume (30 Days)
3.0M
119.9K
Earning Date
05-08-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.33
Revenue
$76,201,000.00
$284,203,000.00
Revenue This Year
N/A
$9.18
Revenue Next Year
$7.61
$8.23
P/E Ratio
$22.58
$73.91
Revenue Growth
N/A
N/A
52 Week Low
$1.72
$17.19
52 Week High
$8.21
$28.44

Technical Indicators

Market Signals
Indicator
CTMX
MCFT
Relative Strength Index (RSI) 49.00 49.77
Support Level $2.82 $23.21
Resistance Level $3.96 $25.83
Average True Range (ATR) 0.15 0.95
MACD -0.00 -0.02
Stochastic Oscillator 49.66 41.81

Price Performance

Historical Comparison
CTMX
MCFT

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About MCFT MasterCraft Boat Holdings Inc.

MasterCraft Boat Holdings Inc designs, manufactures, and markets performance sport boats and outboard boats. The company is based in the United States and operates in three brand-specific segments. The MasterCraft segment generates the majority of the company's revenue and includes inboard boats for water skiing, wakeboarding, and wake surfing. The Pontoon segment produces pontoon boats at its Owosso, Michigan facility. Pontoon boats are used for general recreational boating. The Aviara segment produces luxury day boats at its Merritt Island, Florida facility. Aviara boats are used for general recreational boating.

Share on Social Networks: